Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Nanomedicine expert joins Rice faculty: Gang Bao combines genetic, nano and imaging techniques to fight disease

Gang Bao will bring his expertise in precision genome engineering, nanotechnology and molecular imaging to Rice's Department of Bioengineering through a grant from the Cancer Prevention and Research Institute of Texas. Credit: Jeff Fitlow/Rice University
Gang Bao will bring his expertise in precision genome engineering, nanotechnology and molecular imaging to Rice's Department of Bioengineering through a grant from the Cancer Prevention and Research Institute of Texas.

Credit: Jeff Fitlow/Rice University

Abstract:
Gang Bao will bring a host of new expertise to Rice University's part in the fight against cancer -- and many other diseases -- when he joins the faculty March 1.

Nanomedicine expert joins Rice faculty: Gang Bao combines genetic, nano and imaging techniques to fight disease

Houston, TX | Posted on December 17th, 2014

The highly regarded Robert A. Milton Chair in Biomedical Engineering at Georgia Institute of Technology and Emory University is the latest recruit to move to Houston with $6 million in funding from the Cancer Prevention and Research Institute of Texas (CPRIT).

Bao and his colleagues, nine of whom will join him at Rice, cover a wide range of research linked primarily by their interest in the genetic roots of disease and the promise of nanotechnology and biomolecular approaches to treat them.

Among their ongoing projects, lab members are working on targeted genome modification using engineered nucleases, the development of magnetic nanoparticles for use as contrast agents and for ablation of tumors and the application of fluorescent molecular beacons for specific RNA detection in living cells.

"Dr. Bao has an outstanding track record of center leadership in developing and applying nanomedicine for disease diagnosis and treatment, and is a fantastic addition to the Rice effort in translational nanomedicine," said Michael Deem, chair of the Department of Bioengineering and the John W. Cox Professor of Biochemical and Genetic Engineering.

"His work in the mid-2000s involved groundbreaking contributions to the molecular imaging field, and he has turned to nanomedicine and nanomaterials-based interventions, for example, with special contributions to the isolation of specific cell types from differentiating human pluripotent stem cells. Most recently, Dr. Bao has made major contributions to the use of the CRISPR/Cas9 system for genome editing," Deem said.

The opportunity to work at Rice's BioScience Research Collaborative, with its close connections and proximity to the Texas Medical Center, made the offer too good to resist, said Bao, who will be the Foyt Family Professor in the Department of Bioengineering and the CPRIT Senior Scholar in Cancer Research at Rice.

"One thing I really like is that this building is right in the Texas Medical Center, very close to (the University of Texas) MD Anderson (Cancer Center), Texas Children's (Hospital) and Baylor (College of Medicine)," he said. "For cancer research, this will make it much easier for me to work with colleagues at MD Anderson, a few blocks away, or at Baylor.

"Another attraction, really, is that the undergraduate programs at Rice are super strong. I always want to attract undergraduates to my lab to do research," he said.

Along with his lab, Bao brings his Nanomedicine Center for Nucleoprotein Machines to Rice. The National Institutes of Health-funded center is developing gene correction techniques to address an estimated 6,000 single-gene disorders. Their first target is sickle cell disease, caused by a single mutation in the beta-globin gene. The mutation causes the body to make sticky, crescent-shaped red blood cells that contain abnormal hemoglobin and can block blood flow in limbs and organs.

Bao calls the tool he and his team created to treat such mutations "nanoscissors," engineered nucleases that cut DNA strands at a specific site. "We have been working on sickle cell disease since 2008," he said. "We are testing an idea to take hematopoietic stem cells from a patient's bone marrow and deliver our nanoscissors into those cells. These nanoscissors generate a cut near the mutation and deliver a correction template that repairs the DNA cut and fixes the mutation. The gene-corrected stem cells will produce normal red blood cells in the patient to replace sickle cells."

The need is critical because there is no widely available cure for the disease, he said. "In theory, 15 percent of patients could be cured with a bone marrow transplant from a matching donor. In reality, only 5 percent or fewer patients have the opportunity to be cured by this therapy."

Bao hopes to have the technology ready for human trials in 2018, and if successful, use it to treat other single-gene disorders, including HIV. "There, we'd use nanoscissors to damage the viral genome that integrated into host cells. And there's potential for this to be used to treat other infectious diseases and cancer," he said.

Bao and his colleagues are heavily invested in nanotechnology. The lab has developed polymer-coated superparamagnetic iron oxide nanoparticles that can be modified to target tumors and serve as a contrast agent for magnetic resonance imaging in cancer diagnosis. The same nanoparticles can be used to deliver anticancer drug molecules and, under an applied alternating magnetic field, could generate local heat to kill cancer cells. "The synergistic effect of an anticancer drug and hyperthermia could make cancer therapy more effective," he said.

To reduce side effects, Bao and his team plan to increase the accumulation of drug-carrying magnetic nanoparticles in the tumor by attracting them to tumors, even deep within tissue, by applying a magnetic field. "If the tumor is close to the surface, you can actually mount magnets to the skin as a way to apply the field," Bao said. "But in deep tissue, that may not work. You might have to put the patient in a large machine to apply the field and generate high nanoparticle accumulation in tumors." The technology for such deep-tissue targeting "may take another 10 years," he said.

He said iron oxide nanoparticles might also be embedded in stem cells that could then be directed around the body with magnetic fields.

####

About Rice University
Located on a 300-acre forested campus in Houston, Rice University is consistently ranked among the nation's top 20 universities by U.S. News & World Report. Rice has highly respected schools of Architecture, Business, Continuing Studies, Engineering, Humanities, Music, Natural Sciences and Social Sciences and is home to the Baker Institute for Public Policy. With 3,920 undergraduates and 2,567 graduate students, Rice's undergraduate student-to-faculty ratio is just over 6-to-1. Its residential college system builds close-knit communities and lifelong friendships, just one reason why Rice is highly ranked for best quality of life by the Princeton Review and for best value among private universities by Kiplinger's Personal Finance.

Follow Rice News and Media Relations via Twitter @RiceUNews

For more information, please click here

Contacts:
Jeff Falk
713-348-6775


Mike Williams
713-348-6728

Copyright © Rice University

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Laboratory of Biomolecular Engineering and Nanomedicine (Bao Lab):

Rice Department of Bioengineering:

Related News Press

News and information

Researchers develop artificial building blocks of life March 8th, 2024

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Two-dimensional bimetallic selenium-containing metal-organic frameworks and their calcinated derivatives as electrocatalysts for overall water splitting March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

Cancer

University of Toronto researchers discover new lipid nanoparticle that shows muscle-specific mRNA delivery, reduces off-target effects: Study findings make significant contribution to generating tissue-specific ionizable lipids and prompts rethinking of mRNA vaccine design princi December 8th, 2023

Super-efficient laser light-induced detection of cancer cell-derived nanoparticles: Skipping ultracentrifugation, detection time reduced from hours to minutes! October 6th, 2023

The medicine of the future could be artificial life forms October 6th, 2023

Chung-Ang University researchers develop novel DNA biosensor for early diagnosis of cervical cancer: The electrochemical sensor, made of a graphitic nano-onion/molybdenum disulfide nanosheet composite, detects human papillomavirus (HPV)-16 and HPV-18, with high specificity September 8th, 2023

Academic/Education

Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024

Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022

National Space Society Helps Fund Expanding Frontier’s Brownsville Summer Entrepreneur Academy: National Space Society and Club for the Future to Support Youth Development Program in South Texas June 24th, 2022

How a physicist aims to reduce the noise in quantum computing: NAU assistant professor Ryan Behunin received an NSF CAREER grant to study how to reduce the noise produced in the process of quantum computing, which will make it better and more practical April 1st, 2022

Nanomedicine

High-tech 'paint' could spare patients repeated surgeries March 8th, 2024

Researchers develop artificial building blocks of life March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Appointments/Promotions/New hires/Resignations/Deaths

The National Space Society Mourns the Passing of Robert Krone, Founder of the Kepler Space Institute: Krone's Visionary and Humanistic Approach to the Study of Space Communities and Settlement Was Unique September 22nd, 2021

Leibniz Prize winner Professor Dr. Oliver G. Schmidt moves to Chemnitz University of Technology: President Professor Dr. Gerd Strohmeier refers to an 'absolute top transfer' September 10th, 2021

JEOL USA Welcomes New Managing Director, Hidetaka Sawada April 19th, 2021

The National Space Society Remembers Ben Bova : NSS Mourns the Loss of a Visionary NSS Leader December 2nd, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project